ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,098Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 143

$820K Total Retail Price of All Prescriptions

Rank: 8 out of 143

497 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 497 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 497 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 7,927 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$101 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
SIMVASTATIN 304 303 1 2
AMLODIPINE BESYLATE 260 257 2 4
ATORVASTATIN CALCIUM 259 258 3 7
LOSARTAN-HYDROCHLOROTHIAZIDE 254 249 4 52
ATENOLOL 178 178 5 11
HYDROCHLOROTHIAZIDE 169 168 6 10
LOSARTAN POTASSIUM 148 147 7 19
CRESTOR 144 144 8 17
AZITHROMYCIN 134 131 9 31
ZETIA 133 133 10 75
LEVOTHYROXINE SODIUM 132 124 11 3
FUROSEMIDE 128 124 12 6
OMEPRAZOLE 118 115 13 5
TAMSULOSIN HCL 116 116 14 28
SYNTHROID 115 115 15 24
SERTRALINE HCL 108 108 16 23
WARFARIN SODIUM 102 102 17 15
TRAZODONE HCL 100 92 18 59
LISINOPRIL 100 100 18 1
POTASSIUM CHLORIDE 99 93 20 34
PRAVASTATIN SODIUM 98 98 21 9
VYTORIN 97 86 22 176
METFORMIN HCL 93 88 23 8
ACTOS 88 88 24 181
DIOVAN 82 82 25 26
LIPITOR 78 78 26 57
GLIMEPIRIDE 78 74 26 27
NIASPAN 71 71 28 105
PIROXICAM 70 69 29 193
JANUVIA 68 68 30 54
MIRTAZAPINE 67 67 31 30
PANTOPRAZOLE SODIUM 65 65 32 43
TRIAMTERENE-HCTZ 64 60 33 89
ZOLPIDEM TARTRATE 63 62 34 13
ALENDRONATE SODIUM 62 58 35 40
NEXIUM 62 58 35 32
DONEPEZIL HCL 59 59 37 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 55 38 21
CARVEDILOL 55 55 39 22
DIOVAN HCT 54 51 40 60
CITALOPRAM HBR 51 51 41 25
ALLOPURINOL 50 49 42 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.